Cargando…
Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients
Immunosuppressive molecules are valuable prognostic biomarkers across different cancer types. Leukocyte immunoglobulin like receptor subfamily B1 (LILRB1) is considered to be an immunosuppressive molecule, which is an important receptor of human leukocyte antigen G. However, the clinical significanc...
Autores principales: | Zhang, Yawei, Wang, Han, Xu, Xiaoyu, Liu, Huifang, Hao, Tengfei, Yin, Songcheng, Zhang, Changhua, He, Yulong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415088/ https://www.ncbi.nlm.nih.gov/pubmed/34485116 http://dx.doi.org/10.3389/fonc.2021.668707 |
Ejemplares similares
-
LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023) -
Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer
por: Mao, Deli, et al.
Publicado: (2021) -
High expression of MRE11 correlates with poor prognosis in gastric carcinoma
por: Li, Junqing, et al.
Publicado: (2019) -
Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
por: Zou, Renheng, et al.
Publicado: (2023) -
Clinicopathological characteristics and prognosis of adolescents and young adults with gastric cancer after gastrectomy: a propensity score matching analysis
por: Chu, Hongwu, et al.
Publicado: (2023)